Brain Metastasis Therapeutics Market Global Industry Analysis, size, share and Forecast 2016-2026 November 2016 Report Id : REP-GB-1360 Status : Ongoing Category : Healthcare, Pharmaceuticals & Medical Devices ©2015 Future Market Insights, All Rights Reserved About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. Research Capabilities Customized Research Syndicated Research Investment Research Social Media Research Customized Research Syndicated Research Investment Research Social Media Research Sector Coverage Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Subscription Information For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com ©2015 Future Market Insights, All Rights Reserved 2 Research Methodology (1/2) Systematic Research Approach 1 Market profiling 2 Formulating discussion guide 3 Developing list of respondents 4 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. PMR formulates a detailed discussion guide to conduct expert and industry interviews PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts Data collection PMR conducts interviews with industry experts, industry players, distributors and retailers Data validation Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data 5 6 Data analysis Insights 7 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry PMR delivers industry insights and information in the required format (PDF) Data Collection Research & Intelligence Data Filter & Analysis Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Actionable Insights A Primary Research B SOLUTION Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments Primary Research # Linkedin Zoominfo Salesforce Avention Business Solution Desk Research C Key industry experts Channel study Developments Market dynamics Products Conclusions Company Analysis Secondary Research # Company websites Company annual reports White papers Financial reports Paid Publications# Factiva GBI Genios Meltwater # includes sources of databases ©2015 Future Market Insights, All Rights Reserved 3 Brain Metastasis Therapeutics Market Brain Metastasis Therapeutics Market Global Industry Analysis, size, share and Forecast 2016-2026 Brain metastasis is a type of cancer that usually occurs due to the spread of cancerous cells to brain. Thus, it is also known as metastatic brain tumor or secondary brain cancer, while in primary brain cancer the tumor occurs in the brain. Brain metastasis is common as compared to the primary brain cancer.Brain metastasis is a major complication of systemic cancer and is one of the major reasons causing morbidity and mortality in cancer patients.The common type of cancer that spread to the brain are breast cancer, lung cancer, melanoma, renal cell carcinoma and colon. The cancer may spread to any part of brain but it is commonly found in the brain cerebrum. Cerebellum and stem cells are rarely found to be affected by brain metastasis. Brain metastasis may be single tumor or multiple, although multiple brain metastasis is common. The symptoms associated with brain metastasis are edema, seizure and severe headache. Therefore the first line of treatment for brain metastasis is treating the symptoms. Brain Metastasis Therapeutics Market: Drivers & Restraints The global brain metastasis therapeutics market is driven by the increasing need of treatment for symptoms associated with brain metastasis. Also, the chemotherapeutic agents are known to be the primary tools for cancer treatment which are estimated to increase the overall brain metastasis therapeutic market. The increased prevalence of cancer that spread to the brain are also expected to drive the global metastasis therapeutics market. Though the market seems to be opportunistic in the forecast period there are some factors such as high cost of treatment and side effects associated with the chemotherapy are expected to restrain the growth of brain metastasis therapeutics market. ©2015 Future Market Insights, All Rights Reserved 4 Brain Metastasis Therapeutics Market Brain Metastasis Therapeutics Market: Segmentation Brain metastasis therapeutics market is segmented on the basis of treatment type, end user, and region. Based on treatment, the global brain metastasis therapeutics market is segmented into: Radiation therapy Chemotherapy Targeted therapy Anticonvulsants Corticosteroids Based on end use, the global brain metastasis therapeutics market is segmented into the following: Cancer Hospitals ©2015 Future Market Insights, All Rights Reserved 5 Brain Metastasis Therapeutics Market Clinics Cancer Research Centers Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1360 Brain Metastasis Therapeutics Market: Overview Chemotherapeutic drugs segment would hold maximum market share in overall brain metastasis market owing to widespread availability of variety of chemotherapeutic agents for the brain metastasis cancer treatment. The first line of treatment for brain metastasis is the treatments of symptoms through anticonvulsants and corticosteroids thus the market for these segments are expected to grow at faster rate over the forecast period. According to the American Association of Neurological Surgeons (AANS), in U.S, every year approximately 170,000 new cases of brain metastasis are diagnosed due to which the global brain metastasis market is estimated grow during the forecast period. Brain Metastasis Therapeutics Market: Region-wise Outlook Depending on geographic regions, global brain metastasis therapeutics market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. ©2015 Future Market Insights, All Rights Reserved 6 Brain Metastasis Therapeutics Market Geographically, North America represents the largest regional market for brain metastasis therapeutics owing to high incidence rate of cancer. North America is followed by Europe and APEJ in terms of the increasing incidence of cancer. In Asia Pacific and Latin America, the market is expected to grow due to increase in healthcare awareness, continuously improving economy leading to increased affordability and relatively less competition as compared to that of developed regions of North America and Europe. It is also expected that a large percentage of cases which go unnoticed in developing countries will be recognized with advancing diagnostics and lead to a better market opportunity for therapeutics in Asia pacific. Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1360 Brain Metastasis Therapeutics Market: Key Players Some of the major companies operating in the development and marketing of brain metastasis drugs includes Bayer AG, Pfizer Inc., Sanofi, F. Hoffmann-La Roche Ltd., Eli Lilly & Company, Novartis AG, GlaxoSmithKline, Merck & Co., Inc., AstraZeneca and AngioChem Inc. Click here to Order a free sample ©2015 Future Market Insights, All Rights Reserved 7 To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Thank You Future Market Insights Global & Consulting Private Limited (FMI) ©2015 Future Market Insights, All Rights Reserved 8
© Copyright 2024